Real-world Experience in Treatment of Donor-Derived Hepatitis C Virus in Kidney Transplant Recipients with Delayed Initiation, Shortened Course Glecaprevir/pibrentasvir Versus Standard of Care.
TRANSPLANT INFECTIOUS DISEASE（2024）
关键词
direct-acting antiviral agents,infectious,hepatitis C,kidney disease,kidney transplantation,sustained virologic response,viral
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要